Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22939117 | 0.94 | KDM4E (0.42) | KDM4EATML3MBTL1POLBALDH1A1 | |
| SCHEMBL17146739 | 0.87 | KDM4E (0.56) | KDM4EATML3MBTL1POLBALDH1A1 | |
| SCHEMBL25638804 | 0.85 | KDM4E (0.54) | KDM4EATML3MBTL1POLBALDH1A1 | |
| SCHEMBL22939042 | 0.84 | KDM4E (0.42) | KDM4EATML3MBTL1POLBALDH1A1 | |
| SCHEMBL22939490 | 0.84 | KDM4E (0.42) | KDM4EATML3MBTL1POLBALDH1A1 | |
| SCHEMBL22939488 | 0.84 | KDM4E (0.42) | KDM4EATML3MBTL1POLBALDH1A1 | |
| SCHEMBL22939043 | 0.84 | KDM4E (0.52) | KDM4EATML3MBTL1POLBALDH1A1 | |
| SCHEMBL20086174 | 0.81 | KDM4E (0.48) | KDM4EATML3MBTL1POLBALDH1A1 | |
| SCHEMBL17146719 | 0.81 | KDM4E (0.48) | KDM4EATML3MBTL1POLBALDH1A1 | |
| SCHEMBL20857772 | 0.80 | KDM4E (0.44) | KDM4EATML3MBTL1POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708355-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-25 | — | — | US | disclosed |
| US-20210032225-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210032225-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, BRD1 | KDM4E 1758/4885ATM 3797/4885L3MBTL1 571/4885 |
| US-11708355-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, BRD1 | KDM4E 1758/4885ATM 3797/4885L3MBTL1 571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.